JP2023531496A5 - - Google Patents
Info
- Publication number
- JP2023531496A5 JP2023531496A5 JP2022579000A JP2022579000A JP2023531496A5 JP 2023531496 A5 JP2023531496 A5 JP 2023531496A5 JP 2022579000 A JP2022579000 A JP 2022579000A JP 2022579000 A JP2022579000 A JP 2022579000A JP 2023531496 A5 JP2023531496 A5 JP 2023531496A5
- Authority
- JP
- Japan
- Prior art keywords
- fusion protein
- protein according
- terminus
- recombinant polypeptide
- cytokine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063044335P | 2020-06-25 | 2020-06-25 | |
| US63/044,335 | 2020-06-25 | ||
| US202163197875P | 2021-06-07 | 2021-06-07 | |
| US202163197944P | 2021-06-07 | 2021-06-07 | |
| US63/197,944 | 2021-06-07 | ||
| US63/197,875 | 2021-06-07 | ||
| PCT/US2021/038909 WO2021262985A1 (en) | 2020-06-25 | 2021-06-24 | Cytokine conjugates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023531496A JP2023531496A (ja) | 2023-07-24 |
| JP2023531496A5 true JP2023531496A5 (https=) | 2024-07-02 |
Family
ID=79281847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022579000A Pending JP2023531496A (ja) | 2020-06-25 | 2021-06-24 | サイトカインコンジュゲート |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230265146A1 (https=) |
| EP (1) | EP4171609A4 (https=) |
| JP (1) | JP2023531496A (https=) |
| KR (1) | KR20230042014A (https=) |
| CN (1) | CN116096730A (https=) |
| AU (1) | AU2021296605A1 (https=) |
| BR (1) | BR112022026248A2 (https=) |
| CA (1) | CA3180251A1 (https=) |
| CO (1) | CO2023000048A2 (https=) |
| IL (1) | IL298626A (https=) |
| MX (1) | MX2022016389A (https=) |
| PH (1) | PH12022553408A1 (https=) |
| WO (1) | WO2021262985A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250114489A1 (en) * | 2022-02-15 | 2025-04-10 | Tagworks Pharmaceuticals B.V. | Masked il12 protein |
| IL320318A (en) * | 2022-10-19 | 2025-06-01 | Kalivir Immunotherapeutics Inc | Nucleic acids encoding tgf-beta inhibitor and il-12 and uses thereof |
| WO2025122957A1 (en) | 2023-12-08 | 2025-06-12 | Amunix Pharmaceuticals, Inc. | Protease activatable cytokines and methods for making and using the same |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020077276A1 (en) * | 1999-04-27 | 2002-06-20 | Fredeking Terry M. | Compositions and methods for treating hemorrhagic virus infections and other disorders |
| ES2610356T3 (es) * | 2009-02-03 | 2017-04-27 | Amunix Operating Inc. | Polipéptidos recombinantes extendidos y composiciones que comprenden los mismos |
| US8557961B2 (en) * | 2010-04-02 | 2013-10-15 | Amunix Operating Inc. | Alpha 1-antitrypsin compositions and methods of making and using same |
| JP6355563B2 (ja) * | 2012-02-27 | 2018-07-11 | アムニクス オペレーティング インコーポレイテッド | Ｘｔｅｎ共役組成物およびそれを製造する方法 |
| IL319047A (en) * | 2015-08-28 | 2025-04-01 | Amunix Operating Inc | Chimeric polypeptide composition and methods for its preparation and use |
| JP7285220B2 (ja) * | 2017-05-18 | 2023-06-01 | モデルナティエックス インコーポレイテッド | 連結したインターロイキン－１２（ｉｌ１２）ポリペプチドをコードするポリヌクレオチドを含む脂質ナノ粒子 |
| AU2018393111B2 (en) * | 2017-12-21 | 2025-07-10 | Amunix Pharmaceuticals, Inc. | Release segments and binding compositions comprising same |
| PE20210313A1 (es) * | 2018-03-28 | 2021-02-12 | Bristol Myers Squibb Co | Proteinas de fusion interleucina-2/receptor alfa de interleucina-2 y metodos de uso |
| WO2019222296A1 (en) * | 2018-05-14 | 2019-11-21 | Werewolf Therapeutics, Inc. | Activatable interleukin 12 polypeptides and methods of use thereof |
| EP3849592A4 (en) * | 2018-08-23 | 2022-08-24 | Exalt Therapeutics, LLC | MODIFIED IFNL3 POLYPEPTIDES COMPRISING A PHARMACOKINETIC ENHANCING FRAGMENT AND THEIR USES |
-
2021
- 2021-06-24 WO PCT/US2021/038909 patent/WO2021262985A1/en not_active Ceased
- 2021-06-24 IL IL298626A patent/IL298626A/en unknown
- 2021-06-24 JP JP2022579000A patent/JP2023531496A/ja active Pending
- 2021-06-24 AU AU2021296605A patent/AU2021296605A1/en active Pending
- 2021-06-24 MX MX2022016389A patent/MX2022016389A/es unknown
- 2021-06-24 BR BR112022026248A patent/BR112022026248A2/pt unknown
- 2021-06-24 CA CA3180251A patent/CA3180251A1/en active Pending
- 2021-06-24 CN CN202180045253.9A patent/CN116096730A/zh active Pending
- 2021-06-24 EP EP21828085.7A patent/EP4171609A4/en active Pending
- 2021-06-24 KR KR1020237002104A patent/KR20230042014A/ko active Pending
- 2021-06-24 PH PH1/2022/553408A patent/PH12022553408A1/en unknown
-
2022
- 2022-12-02 US US18/073,935 patent/US20230265146A1/en active Pending
-
2023
- 2023-01-04 CO CONC2023/0000048A patent/CO2023000048A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023531496A5 (https=) | ||
| Schellekens | Factors influencing the immunogenicity of therapeutic proteins | |
| JP2024503265A5 (https=) | ||
| JP2016537340A5 (https=) | ||
| JP2020169191A5 (https=) | ||
| JP2021523878A5 (https=) | ||
| JP2016512213A5 (https=) | ||
| JP2016514132A5 (https=) | ||
| JP2021514661A5 (https=) | ||
| US7083782B2 (en) | Method of treatment using interferon-tau | |
| US11993640B2 (en) | Treating inflammatory lung disease | |
| ES2329204T3 (es) | Composicion antiviral que comprende interferon en forma de gotas nasales. | |
| JP2020501510A5 (https=) | ||
| JP2021001184A (ja) | ペグ化インターフェロンのための投薬計画 | |
| US9068016B2 (en) | Conjugates for the treatment of mesothelioma | |
| RU2009104749A (ru) | Рекомбинантные белки, подобные человеческому интреферону | |
| CA2311648A1 (en) | Ifnar2/ifn complex | |
| JP2024525213A5 (https=) | ||
| Sirbu et al. | History of interferon treatments in multiple sclerosis-60 years of progress | |
| CN101848727A (zh) | 脱铁乳铁蛋白组合物及其用于治疗病毒性丙型肝炎的方法 | |
| JP2003525907A (ja) | Ｈｉｖ免疫アジュバント治療 | |
| Crockett et al. | Side effects and toxicity of interferon in the treatment of recurrent respiratory papillomatosis | |
| WO2011098644A2 (es) | Composiciones para el tratamiento de enfermedades infecciosas y tumorales | |
| US20060134750A1 (en) | Method of treatment using interferon-tau | |
| TW528599B (en) | Stimulation of host defense mechanisms against viral challenges |